Llwytho...
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
With conventional treatments for primary immunodeficiency diseases (PIDs), such as allogeneic stem cell transplantation or autologous gene therapy, still facing important challenges, the rapid development of genome editing technologies to more accurately correct the mutations underlying the onset of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hum Gene Ther |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Mary Ann Liebert, Inc., publishers
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612852/ https://ncbi.nlm.nih.gov/pubmed/32935622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2020.185 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|